Council Decision (EU) 2023/1493 of 26 June 2023 establishing the position to be taken on behalf of the European Union within the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community as regards the adoption of a decision adding two newly adopted Union acts to Annex 2 to the Windsor Framework

• CELEX: Decision (EU) 2023/1493
• Articles: 4

Article 1

The position to be taken on behalf of the European Union within the Joint Committee established by Article 164(1) of the Withdrawal Agreement as regards the adoption of a decision adding two newly adopted Union acts to Annex 2 to the Windsor Framework is set out in the draft decision of the Joint Committee attached to this Decision.

Article 1

1.   Regulation (EU) 2023/1182 of the European Parliament and of the Council of 14 June 2023 on specific rules relating to medicinal products for human use intended to be placed on the market in Northern Ireland and amending Directive 2001/83/EC  ( 3 ) , insofar as it does not amend Directive 2001/83/EC, shall be added to Annex 2 to the Windsor Framework under point 20 ‘Medicinal products’.

2.   Regulation (EU) 2023/1231 of the European Parliament and of the Council of 14 June 2023 on specific rules relating to the entry into Northern Ireland from other parts of the United Kingdom of certain consignments of retail goods, plants for planting, seed potatoes, machinery and certain vehicles operated for agricultural or forestry purposes, as well as non-commercial movements of certain pet animals into Northern Ireland  ( 4 ) shall be added to Annex 2 to the Windsor Framework under point 44 ‘Sanitary and phytosanitary – Other’.

Article 2

This Decision shall enter into force on the date of its adoption.

Article 2

This Decision shall enter into force on the day following that of its adoption.